ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

Comment period for biospecimen network proposal extended.

January 16, 2004

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

December 3, 1999